Literature DB >> 18645268

Is there any clinical parameter able to predict prostate cancer after initial diagnosis of atypical small acinar proliferation?

Luigi Mearini1, Elisabetta Costantini, Guido Bellezza, Antonio Cavaliere, Alessandro Zucchi, Vittorio Bini, Massimo Porena.   

Abstract

INTRODUCTION: Tissue samples from prostate biopsy may contain atypical small acinar proliferation (ASAP): present guidelines recommend a repeat biopsy policy. This study attempted to identify clinical patterns that help predict cancer detection at second biopsy.
MATERIALS AND METHODS: From 1999 to 2005, 1,274 patients underwent a prostate biopsy: in 5.9% ASAP was found, and patients underwent a second biopsy. Uni- and multivariate analysis compared the clinical patterns of cancer patients with the no cancer group at second biopsy.
RESULTS: Univariate analysis showed significant differences in PSA ratio density, prostate volume, final PSA values and Delta PSA; at multivariate logistic regression analysis, only PSA ratio (OR = 0.743, 95% CI 0.620-0.891) and prostate volume (OR = 0.960, 95% CI 0.924-0.998) were predictive of malignancy.
CONCLUSIONS: In our experience, PSA ratio and prostate volume seem to be independent predictors of prostate cancer at re-biopsy. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645268     DOI: 10.1159/000137637

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Atypical Small Acinar Proliferation and High Grade Prostatic Intraepithelial Neoplasia: Should We Be Concerned? An Observational Cohort Study with a Minimum Follow-Up of 3 Years.

Authors:  Vinaya Srirangam; Bhavan Prasad Rai; Ahmed Abroaf; Samita Agarwal; Sergey Tadtayev; Charlotte Foley; Tim Lane; Jim Adshead; Nikhil Vasdev
Journal:  Curr Urol       Date:  2017-10-22

2.  Predictive factors of prostate cancer at repeat biopsy in patients with an initial diagnosis of atypical small acinar proliferation of the prostate.

Authors:  Jae Hyun Ryu; Yun Beom Kim; Jeong Ki Lee; Yoon Jung Kim; Tae Young Jung
Journal:  Korean J Urol       Date:  2010-11-17

3.  Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.

Authors:  Li Wang; Pei-Gen Xie; Ying-Li Lin; Jian-Guo Ma; Wen-Ping Li
Journal:  Med Sci Monit       Date:  2014-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.